perindopril has been researched along with Neurofibromatosis 1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeon, H; Kim, DW; Kim, HJ; Kim, IY; Kim, MJ; Kim, S; Kim, SR; Lee, DW; Lee, SB; Lee, W; Rhee, H; Seong, EY; Song, SH; Ye, BM | 1 |
1 other study(ies) available for perindopril and Neurofibromatosis 1
| Article | Year |
|---|---|
Immunoglobulin A nephropathy in a patient with neurofibromatosis type 1: A case report and literature review.
Topics: Angiotensin-Converting Enzyme Inhibitors; Glomerulonephritis, IGA; Humans; Male; Middle Aged; Neurofibromatosis 1; Perindopril | 2021 |